These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26475728)

  • 1. Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective.
    Sabater-Galindo M; Fernandez-Llimos F; Sabater-Hernández D; Martínez-Martínez F; Benrimoj SI
    Patient Educ Couns; 2016 Mar; 99(3):339-347. PubMed ID: 26475728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' expectations of the role of the community pharmacist: Development and testing of a conceptual model.
    Sabater-Galindo M; Ruiz de Maya S; Benrimoj SI; Gastelurrutia MA; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(2):313-320. PubMed ID: 27185270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural and process aspects of pharmacy quality: older adults' perceptions.
    Shiyanbola OO; Mott DA; Croes KD
    Int J Clin Pharm; 2016 Feb; 38(1):96-106. PubMed ID: 26499502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
    Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
    BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining professional pharmacy services in community pharmacy.
    Moullin JC; Sabater-Hernández D; Fernandez-Llimos F; Benrimoj SI
    Res Social Adm Pharm; 2013; 9(6):989-95. PubMed ID: 23591411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring patient expectations for pharmacist-provided literacy-sensitive communication.
    Collum JL; Marcy TR; Stevens EL; Burns CF; Miller MJ
    Res Social Adm Pharm; 2013; 9(5):626-32. PubMed ID: 22835713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Nationwide Study of Pharmacists' Perception of the Impact of Medicare Part D on the Pharmacist-Patient Relationship.
    Spooner JJ; Spotts H; Khan S
    Consult Pharm; 2017 Oct; 32(10):629-644. PubMed ID: 28992824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication.
    Ilardo ML; Speciale A
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31952127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and impact of pharmacists in Spain: a scoping review.
    Saavedra-Mitjans M; Ferrand É; Garin N; Bussières JF
    Int J Clin Pharm; 2018 Dec; 40(6):1430-1442. PubMed ID: 30367376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of Estonian consumer expectations from the pharmacy service and a comparison with the opinions of pharmacists.
    Villako P; Raal A
    Pharm World Sci; 2007 Oct; 29(5):546-50. PubMed ID: 17497224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies.
    Bacci JL; Coley KC; McGrath K; Abraham O; Adams AJ; McGivney MS
    J Am Pharm Assoc (2003); 2016; 56(3):257-265.e2. PubMed ID: 27053276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role theory: literature review and implications for patient-pharmacist interactions.
    Guirguis LM; Chewning BA
    Res Social Adm Pharm; 2005 Dec; 1(4):483-507. PubMed ID: 17138492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is known about community pharmacy supply of naloxone? A scoping review.
    Nielsen S; Van Hout MC
    Int J Drug Policy; 2016 Jun; 32():24-33. PubMed ID: 26949189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.